Exela 2023 sachliches Forum Forum: Community User: Thoken88
The Company expects to report total revenues of $1.08 billion for the year ended December 31, 2022, compared to total revenues of $1.17 billion for the year ended December 31, 2021. The Company expects to report a net loss for the year ended December 31, 2022 higher than the net loss of $142 million reported for the year ended December 31, 2021. The expected increase in net loss is primarily the result of cost inflation, the below described goodwill impairment charges, and revenue decline (but cannot be finalized until goodwill impairment is finalized). Similar to the nine months ended September 30, 2022, changes in certain factors such as the Company’s growth rate and recent trends in the Company’s market capitalization represented a triggering event for our annual impairment analysis. As of the date hereof, the Company is still finalizing its goodwill impairment analysis. The foregoing figures are preliminary and unaudited and are prepared in accordance with U.S. generally accepted accounting principles.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | LVMH Hauptdiskussion | -3,21 % | |
| 2 | DAX Prognose / Germany 40 | +0,43 % | |
| 3 | Der Gold Club von Susiwong | +2,17 % | |
| 4 | DAX / Germany 40 Hauptdiskussion | +0,43 % | |
| 5 | Gossamer Bio Hauptforum | -0,67 % | |
| 6 | ATOS Hauptdiskussion | +2,29 % | |
| 7 | SIVERS IMA HLDG Hauptdiskussion | +10,77 % | |
| 8 | Critical Infrastructure Technologies Hauptdiskussion | +13,44 % | |
| 9 | Quantum Crypto Security | +3,86 % | |
| 10 | VONOVIA Hauptdiskussion | +2,06 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | LVMH Hauptdiskussion | -3,28 % | |
| 2 | ATOS Hauptdiskussion | +2,29 % | |
| 3 | Gossamer Bio Hauptforum | -0,67 % | |
| 4 | SIVERS IMA HLDG Hauptdiskussion | +11,44 % | |
| 5 | Critical Infrastructure Technologies Hauptdiskussion | +13,44 % | |
| 6 | Quantum Crypto Security | +3,86 % | |
| 7 | VONOVIA Hauptdiskussion | +2,09 % | |
| 8 | mint inco | +42,53 % | |
| 9 | Novo Nordisk nach Split | +2,53 % | |
| 10 | SINGULUS Hauptdiskussion | +9,40 % | Alle Diskussionen |